280
Views
124
CrossRef citations to date
0
Altmetric
Review

Regulatory mechanisms of microRNAs involvement in cancer

the strange case of Dr Jekyll and Mr Hyde

, , , & , MD PhD
Pages 1009-1019 | Published online: 31 Jul 2007

Bibliography

  • HE L, HANNON GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. (2004) 5:522-531.
  • LAGOS-QUINTANA M, RAUHUT R, LENDECKEL W, TUSCHL T: Identification of novel genes coding for small expressed RNAs. Science (2001) 294:853-858.
  • LAU NC, LIM LP, WEINSTEIN EG, BARTEL DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 294:858-862.
  • LEE RC, AMBROS V: An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 294:862-864.
  • LEE Y, KIM M, HAN J et al.: MicroRNA genes are transcribed by RNA polymerase II. EMBO J. (2004) 23:4051-4060.
  • CAI X, HAGEDORN CH, CULLEN BR: Human nicroRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (2004) 10:1957-1966.
  • PFEFFER S, SEWER A, LAGOS-QUINTANA M et al.: Identification of microRNAs of the herpesvirus family. Nat. Methods (2005) 2:269-276.
  • AMBROS V: The functions of animal microRNAs. Nature (2004) 431:350-355.
  • BARTEL DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116:281-297.
  • PASQUINELLI AE, HUNTER S, BRACHT J: MicroRNAs: a developing story. Curr. Opin. Genet. Dev. (2005) 15:200-205.
  • HARFE BD: MicroRNAs in vertebrate development. Curr. Opin. Genet. Dev. (2005) 15:410-415.
  • BERNSTEIN E, KIM SY, CARMELL MA et al.: Dicer is essential for mouse development. Nat. Genet. (2003) 35:215-217.
  • HOUBAVIY HB, MURRAY MF, SHARP PA: Embryonic stem cell-specific microRNAs. Dev. Cell (2003) 5:351-358.
  • SUH MR, LEE Y, KIM JY et al.: Human embryonic stem cells express a unique set of microRNAs. Dev. Biol. (2004) 270:488-498.
  • KANELLOPOULOU C, MULJO SA, KUNG AL et al.: Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. (2005) 19:489-501.
  • CHEN CZ, LI L, LODISH HF, BARTEL DP: MicroRNAs modulate hematopoietic lineage differentiation. Science (2004) 303:83-85.
  • FAZI F, ROSA A, FATICA A et al.: A minicircuitry comprised of micro RNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell (2005) 123:819-831.
  • FELLI N, FONTANA L, PELOSI E et al.: MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. USA (2005) 102:18081-18086.
  • GARZON R, PICHIORRI F, PALUMBO T et al.: MicroRNA fingerprints durino human megakaryocytopoiesis. Proc. Natl. Acad. Sci. USA (2006) 103:5078-5083.
  • CHENG LC, TAVAZOIE M, DOETSCH F: Stem cells: from epigenetics to microRNAs. Neuron (2005) 46:363-367.
  • CHEN JF, MANDEL EM, THOMSON JM et al.: The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. (2006) 38:228-233.
  • ZHAO Y, SAMAL E, SRIVASTAVA D: Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature (2005) 436:181-182.
  • SEVIGNANI C, CALIN GA, SIRACUSA L, CROCE CM: Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm. Genome (2006) 17:189-202.
  • CALIN GA, DUMITRU CD, SHIMIZU M et al.: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc. Natl. Acad. Sci. USA (2002) 99:15524-15529.
  • MCMANUS MT: MicroRNAs and cancer. Semin. Cancer Biol. (2003) 13:253-258.
  • GREGORY RI, SHIEKHATTAR R: MicroRNA biogenesis and cancer. Cancer Res. (2005) 65:3509-3512.
  • CROCE CM, CALIN GA: miRNAs, cancer, and stem cell division. Cell (2005) 122:6-7.
  • CALIN GA, CROCE CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. (2006) 66:7390-7394.
  • CHEN CZ: MicroRNAs as oncogenes and tumour suppressors. N. Engl. J. Med. (2005) 353:1768-1771.
  • CALIN GA, GARZON R, CIMMINO A, FABBRI M, CROCE CM: MicroRNAs and leukaemias: how strong is the connection? Leuk. Res. (2005) 30:653-655.
  • HWANG HW, MENDELL JT: MicroRNAs in cell proliferation, cell death, and tumourigenesis. Br. J. Cancer (2006) 94:776-780.
  • HAMMOND SM: MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. (2006) 16:4-9.
  • CALIN GA, CROCE CM: MicroRNA signatures in human cancers. Nat. Rev. Cancer (2006) 6:857-866.
  • GARZON R, FABBRI M, CIMMINO A, CALIN GA, CROCE CM: MicroRNA expression and function in cancer. Trends Mol. Med. (2006) 12:580-587.
  • ESQUELA-KERSCHER A, SLACK FJ: Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer (2006) 6:259-269.
  • ZHANG B, PAN X, COBB GP, ANDERSON TA: MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. (2007) 302:1-12.
  • LIU CG, CALIN GA, MELOON B et al.: An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. USA (2004) 101:9740-9744.
  • LU J, GETZ G, MISKA EA et al.: MicroRNA expression profiles classify human cancers. Nature (2005) 435:834-838.
  • SCHMITTGEN TD, JIANG J, LIU Q, YANG L: A high-throughput method to monitor the expression of microRNA precursor. Nucleic Acids Res. (2004) 32:43-53.
  • RAYMOND CK, ROBERTS BS, GARRETT-ENGELE P, LIM LP, JOHNSON JM: Simple, quantitative primer-extension PCR assay for the direct monitoring of microRNAs and short-interfering RNAs. RNA (2005) 11:1737-1744.
  • CUMMINS JM, HE Y, LEARY RJ et al.: The colorectal microRNAome. Proc. Natl. Acad. Sci. USA (2006) 103:3687-3692.
  • NELSON PT, BALDWIN DA, SCEARCE LM, OBERHOLTZER JC, TOBIAS JW, MOURELATOS Z: Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods (2004) 1:155-161.
  • VOLINIA S, CALIN GA, LIU CG et al.: A microRNA expression signature of human solid tumours defines cancer gene targets. Proc. Natl. Acad. Sci. USA (2005) 103:2257-2261.
  • CALIN GA, SEVIGNANI C, DUMITRU CD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA (2004) 101:2999-3004.
  • HUPPI K, VOLFOVSKY N, MACKIEWICZ M et al.: MicroRNAs and genomic instability. Semin. Cancer Biol. (2007) 17:65-73.
  • CALIN GA: Oncogenes and tumour suppressor genes – two different looks of the same gene? Oncol. Reports (1994) 1:987-991.
  • O'DONNELL KA, WENTZEL EA, ZELLER KI, DANG CV, MENDELL JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 435:839-843.
  • HE L, THOMSON JM, HEMANN MT et al.: A microRNA polycistronic as a potential human oncogene. Nature (2005) 435:828-833.
  • ROLDO C, MISSIAGLIA E, HAGAN JP et al.: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. (2006) 24:4677-4684.
  • YANAIHARA N, CAPLEN N, BOWMAN E et al.: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 9:189-198.
  • TAKAMIZAWA J, KONISHI H, YANAGISAWA K et al.: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. (2004) 64:3753-3756.
  • JOHNSON SM, GROSSHANS H, SHINGARA J et al.: RAS is regulated by the let-7 microRNA family. Cell (2005) 120:635-647.
  • BRUECKNER B, STRESEMANN C, KUNER R et al.: The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. (2007) 67:1419-1423.
  • BULLRICH F, FUJII H, CALIN GA et al.: Characterization of the 13q14 tumour suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res. (2001) 61:6640-6648.
  • CALIN GA, TRAPASSO F, SHIMIZU M et al.: Familial cancer associated with a polymorphism in ARLTS1. N. Engl. J. Med. (2005) 352:1667-1676.
  • MIGLIAZZA A, BOSCH F, KOMATSU H et al.: Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukaemia. Blood (2001) 97:2098-2104.
  • CALIN GA, FERRACIN M, CIMMINO A et al.: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukaemia. N. Engl. J. Med. (2005) 353:1793-1801.
  • CIMMINO A, CALIN GA, FABBRI M et al.: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA (2005) 102:13944-13949.
  • MICHAEL MZ, O’ CONNOR SM, VAN HOLST PELLEKAAN NG, YOUNG GP, JAMES RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. (2003) 1:882-891.
  • IORIO MV, FERRACIN M, LIU CG et al.: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. (2005) 65:7065-7070.
  • ALTUVIA Y, LANDGRAF P, LITHWICK G et al.: Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. (2005) 33:2697-2706.
  • SAITO Y, LIANG G, EGGER G et al.: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell (2006) 9:435-443.
  • LUJAMBIO A, ROPERO S, BALLESTAR E et al.: Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. (2007) 67:1424-1429.
  • BARLUND M, MONNI O, KONONEN J et al.: Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res. (2000) 60:5340-5344.
  • MAYR C, HEMANN MT, BARTEL DP: Disrupting the pairing between let-7 and HmgA2 enhances oncogenic transformation. Science (2007) 315:1576-1579.
  • OTA A, TAGAWA H, KARNAN S et al.: Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. (2004) 64:3087-3095.
  • HAYASHITA Y, OSADA H, TATEMATSU Y et al.: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. (2005) 65:9628-9632.
  • BRACKEN AP, CIRO M, COCITO A, HELIN K: E2F target genes: unraveling the biology. Trends Biochem. Sci. (2004) 29:409-417.
  • MATSUMURA I, TANAKA H, KANAKURA Y: E2F1 and c-Myc in cell growth and death. Cell Cycle (2003) 2:333-338.
  • LEONE G, DE GREGORI J, SEARS R, JAKOI L, NEVINS JR: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (1997) 387:422-426.
  • CHAN JA, KRICHEVSKY AM, KOSIK KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. (2005) 65:6029-6033.
  • CIAFRE SA, GALARDI S, MANGIOLA A et al.: Estensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. (2005) 334:1351-1358.
  • CULLY M, YOU H, LEVINE AJ, MAK TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumourigenesis. Nat. Rev. Cancer (2006) 6:184-192.
  • VOORHOEVE PM, LE SAGE C, SCHRIER M et al.: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumours. Cell (2006) 124:1169-1181.
  • EIS PS, TAM W, SUN L et al.: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA (2005) 102:3627-3632.
  • Tam W, Hughes SH, Hayward WS, Besmer P: Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukaemogenesis. J. Virol. (2002) 76:4275-4286.
  • HE H, JAZDZEWSKI K, LI W et al.: The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA (2005) 102:19075-19080.
  • COSTINEAN S, ZANESI N, PEKARSKY Y et al.: Pre-B cell proliferation and lymphoblastic leucemia/high-grade lymphoma in Eμ-miR 155 transgenic mice. Proc. Natl. Acad. Sci. USA (2006) 103:7024-7029.
  • Georgantas RW III, Hildreth R, Morisot S et al.: CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. USA (2007) 104:2750-2755.
  • KLUIVER J, VAN DEN BERG A, DE JONG D et al.: Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene (2007) 26:3769-3776.
  • O'CONNELL RM, TAGANOV KD, BOLDIN MP, CHENG G, BALTIMORE D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA (2007) 104:1604-1609.
  • THAI TH, CALADO DP, CASOLA S et al.: Regulation of the germinal center response by microRNA-155. Science (2007) 316:604-608.
  • RODRIGUEZ A, VIGORITO E, CLARE S et al.: Requirement of bic/microRNA-155 for normal immune function. Science (2007) 316:608-611.
  • HARRIS AL: Hypoxia – a key regulatory factor in tumour growth. Nat. Rev. Cancer (2002) 2:38-47.
  • KULSHRESHTHA R, FERRACIN M, WOJCIK SE et al.: A microRNA signature of hypoxia. Mol. Cell Biol. (2007) 27:1859-1867.
  • HEBERT C, NORRIS K, SCHEPER MA, NIKITAKIS N, SAUK JJ: High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol. Cancer (2007) 6:5.
  • HUA Z, LV Q, YE W et al.: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE (2006) 1:E116.
  • MENG F, HENSON R, LANG M et al.: Involvement of human microRNAs in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology (2006) 130:2113-2129.
  • KRUTZFELDT J, RAJEWSKY N, BRAICH R et al.: Silencing of microRNAs in vivo with ‘antagomirs’. Nature (2005) 438:685-689.
  • WEILER J, HUNZIKER J, HALL J: Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther. (2005) 13:496-502.
  • OROM UA, KAUPPINEN S, LUND A: LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene (2006) 372:137-141.
  • FERRACIN M: MicroRNAs and human tumours. PhD Thesis Dissertation at University of Ferrara (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.